News

Gladstone in the News July 28, 2025

Gladstone Institutes Develops AI-Powered Thinking Microscope

ABC7 News—Steve Finkbeiner, director of the Center for Systems and Therapeutics at Gladstone, describes the revolutionary thinking microscope that his team developed to help identify better treatments for diseases like Alzheimer’s, Parkinson’s, and ALS.

Gladstone Experts ALS Alzheimer’s Disease Parkinson’s Disease Center for Systems and Therapeutics Finkbeiner Lab

Article November 14, 2023

Meet Gladstone: Christina Buselli

Research Associate Christina Buselli describes her work in the Finkbeiner lab, her path to science, and the questions she wishes she could ask her grandfather

Profile Finkbeiner Lab

Article September 27, 2023

When Two Disruptive Technologies Converge

How gene editing and stem cells are working in tandem at Gladstone Institutes to change science and medicine

Deep Dive Stem Cells/iPSCs CRISPR/Gene Editing Srivastava Lab Yamanaka Lab Doudna Lab Conklin Lab Marson Lab Huang Lab Ott Lab

Gladstone in the News October 19, 2022

Hereditary Disease Foundation Announces 2022 Prize Winners for Leadership in Huntington’s Disease Research

Global News Wire—Gladstone Investigator Steve Finkbeiner was awarded the 2022 Leslie Gehry Prize for Innovation in Science. The award recognizes his advancements in developing novel technologies, such as robotic microscopy and deep learning pipelines, that can be used to understand and develop treatments for Huntington’s disease.

Gladstone Experts Huntington’s Disease Center for Systems and Therapeutics Taube-Koret Center for Neurodegenerative Disease Research Finkbeiner Lab Robotic Microscopy

Article April 13, 2021

World’s Largest Public ALS Data Portal Launched

Steve Finkbeiner is leading key components of this unprecedented resource to boost ALS research.

Gladstone Experts ALS Center for Systems and Therapeutics Finkbeiner Lab AI Robotic Microscopy Stem Cells/iPSCs

Gladstone in the News March 30, 2021

AI Spots Cell Structures That Humans Can’t

Nature—Advances in artificial intelligence are enabling scientists to make discoveries from images of cells, by detecting features and patterns that are invisible to the human eye. Senior Investigator Steve Finkbeiner explains how his lab trained an algorithm to detect structures inside unlabeled cells, and differentiate live from dead cells.

Gladstone Experts Taube-Koret Center for Neurodegenerative Disease Research Finkbeiner Lab AI

Article October 13, 2020

Meet Gladstone: Leandro Lima

Learn how a Gladstone bioinformatician is spending his days during shelter-in-place

Profile Finkbeiner Lab

Video May 15, 2020

The Thinking Microscope: Reimagining Science through the Lens of AI and Robotics

Steve Finkbeiner explains how his lab uses machine learning and robotics to find answers to some of the world’s most devastating diseases.

Center for Systems and Therapeutics Neurological Disease Finkbeiner Lab Big Data Robotic Microscopy

Article April 22, 2020

Data-Driven Discovery

Many Gladstone researchers rely on computational approaches, machine learning, and innovative software to make biomedical discoveries.

Gladstone Experts HIV/AIDS Zika Virus Center for HIV Cure Research Center for Systems and Therapeutics Data Science and Biotechnology Neurological Disease Virology Finkbeiner Lab

Video February 20, 2020

Aging: Progress with Rejuvenation and Regeneration

Aging is the single greatest risk factor for developing Alzheimer’s disease, Parkinson’s disease, and other brain diseases.

Gladstone Experts Cardiovascular Disease Neurological Disease Finkbeiner Lab McDevitt Lab Srivastava Lab Aging

Article December 12, 2019

Gladstone’s Evolution of Research

Gladstone began as a single entity with a single purpose. But as the scientists followed the science—unencumbered by the red tape of bureaucracy—the purpose, and the focus, grew.

History Institutional News Neurological Disease Cardiovascular Disease Data Science and Biotechnology Virology Finkbeiner Lab Greene Lab Mahley Lab Mucke Lab

Article October 9, 2019

Connecting the Dots: From Stem Cells to Human Health

Since Shinya Yamanaka discovered a method to create human induced pluripotent stem (iPS) cells, Gladstone researchers have built on this technology to create numerous iPS cell lines, coax iPS cells into a myriad of tissue types, use them as a tool to study disease, and even begin creating therapies using these cells.

Research (Publication) Alzheimer’s Disease Huntington’s Disease Finkbeiner Lab Huang Lab McDevitt Lab Srivastava Lab Yamanaka Lab CRISPR/Gene Editing

Article April 15, 2019

Meet Gladstone: David Cahill

A Seattle native, David grew up exploring the great wild places in this country and beyond. He explains the role of a lab manager at Gladstone, as well as his love of wilderness travel, for which knowing how to pack efficiently is a useful skill.
 

Profile Center for Systems and Therapeutics Finkbeiner Lab

Article September 6, 2018

NIH Funds Initiative to Chart a Course toward New Psychiatric Drugs

The Psychiatric Cell Mapping Initiative is led by researchers at Gladstone and UC San Francisco

Grants News Release Epilepsy Virology Doudna Lab Finkbeiner Lab Krogan Lab

Article April 8, 2018

Deep Learning: A Superhuman Way to Look at Cells

Gladstone and Google AI collaborate to uncover the tip of an iceberg that could transform biomedical science
 

News Release Research (Publication) Alzheimer’s Disease Center for Systems and Therapeutics Neurological Disease Finkbeiner Lab AI